The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Centers for AIDS Research (P30 Clinical Trial Not Allowed) |
93.121, 93.233, 93.242, 93.279, 93.307, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.855, 93.865, 93.866, 93.989 |
PAR-20-106 |
| Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) |
93.121, 93.233, 93.242, 93.279, 93.307, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.855, 93.865, 93.866, 93.989 |
PAR-20-107 |
| National Alzheimers Coordinating Center (U24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-014 |
| IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional) |
93.859 |
PAR-20-102 |
| Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) |
93.859 |
PAR-20-103 |
| Childhood Asthma in Urban Settings -Clinical Research Centers (U01 Clinical Trial Optional) |
93.855 |
RFA-AI-19-073 |
| Childhood Asthma in Urban Settings Clinical Research Network- Leadership Center (UM1 Clinical Trial Required) |
93.855 |
RFA-AI-19-074 |
| Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional) |
93.113 |
RFA-ES-20-006 |
| National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
PAR-20-077 |
| Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-012 |
| HEAL Initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development (R61/R33 - Clinical Trial Not |
93.233, 93.279, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-20-031 |
| Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) |
93.279 |
PAR-20-092 |
| Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
93.394 |
RFA-CA-20-010 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional) |
93.396 |
RFA-CA-20-013 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) |
93.396 |
RFA-CA-20-012 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) |
93.396 |
RFA-CA-20-011 |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
93.394 |
RFA-CA-20-009 |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
93.393 |
RFA-CA-20-008 |
| Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-20-007 |
| Harmonization of Alzheimers Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed) |
93.866 |
PAR-20-099 |
| Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed) |
93.242, 93.399, 93.853, 93.865, 93.867 |
PAR-20-101 |
| Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers (Collaborative U01 Clinical Trial Required) |
93.393, 93.847, 93.866 |
RFA-DK-20-501 |
| Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (BRC) (Collaborative U01 Clinical Trial Required) |
93.393, 93.847, 93.866 |
RFA-DK-20-502 |
| HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional) |
93.121, 93.213, 93.307, 93.350, 93.361, 93.393, 93.846, 93.865 |
RFA-AT-20-004 |
| HIV/AIDS and the Tumor Niche (U54 Clinical Trial Not Allowed) |
93.396 |
RFA-CA-20-016 |
| Genomic Community Resources (U24 Clinical Trial Not Allowed) |
93.172 |
PAR-20-100 |
| HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
93.121, 93.213, 93.273, 93.279, 93.307, 93.361, 93.393, 93.846, 93.853 |
RFA-NS-20-028 |
| Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-19-034 |
| Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed) |
93.113, 93.273, 93.279, 93.307, 93.393, 93.394, 93.395, 93.396, 93.399, 93.853, 93.859 |
PAR-20-097 |
| Biomedical Data Repository (U24 - Clinical Trials Not Allowed) |
93.113, 93.273, 93.279, 93.307, 93.393, 93.394, 93.395, 93.396, 93.399, 93.853, 93.855, 93.859 |
PAR-20-089 |
| NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed) |
93.242 |
PAR-20-096 |
| Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-20-004 |
| Accelerating Medicine Partnership in Parkinsons disease (AMP PD) data use and analysis (U01 Clinical trials not allowed) |
93.853 |
RFA-NS-20-027 |
| NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed) |
93.242 |
PAR-20-094 |
| NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed) |
93.242 |
PAR-20-080 |
| Limited Competition: Microphysiological Systems Database Center (MPS DC) (U24 Clinical Trials Not Allowed) |
93.350 |
RFA-TR-20-002 |
| Medications Development for the Treatment of Alcohol Use Disorder (AUD) or Alcohol-Related Organ Damage (AROD), or the Combination of AUD and AROD (U01 Clinical Trial Optional) |
93.273 |
RFA-AA-20-007 |
| Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-20-005 |
| KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) |
93.847 |
RFA-DK-19-032 |
| Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) |
93.242 |
PAR-20-093 |
Search Results 3001-3040 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
